Literature DB >> 35140402

Mechanisms of inhibition and activation of extrasynaptic αβ GABAA receptors.

Vikram Babu Kasaragod1,2, Martin Mortensen3, Steven W Hardwick4, Ayla A Wahid1, Valentina Dorovykh3, Dimitri Y Chirgadze4, Trevor G Smart5, Paul S Miller6.   

Abstract

Type A GABA (γ-aminobutyric acid) receptors represent a diverse population in the mammalian brain, forming pentamers from combinations of α-, β-, γ-, δ-, ε-, ρ-, θ- and π-subunits1. αβ, α4βδ, α6βδ and α5βγ receptors favour extrasynaptic localization, and mediate an essential persistent (tonic) inhibitory conductance in many regions of the mammalian brain1,2. Mutations of these receptors in humans are linked to epilepsy and insomnia3,4. Altered extrasynaptic receptor function is implicated in insomnia, stroke and Angelman and Fragile X syndromes1,5, and drugs targeting these receptors are used to treat postpartum depression6. Tonic GABAergic responses are moderated to avoid excessive suppression of neuronal communication, and can exhibit high sensitivity to Zn2+ blockade, in contrast to synapse-preferring α1βγ, α2βγ and α3βγ receptor responses5,7-12. Here, to resolve these distinctive features, we determined structures of the predominantly extrasynaptic αβ GABAA receptor class. An inhibited state bound by both the lethal paralysing agent α-cobratoxin13 and Zn2+ was used in comparisons with GABA-Zn2+ and GABA-bound structures. Zn2+ nullifies the GABA response by non-competitively plugging the extracellular end of the pore to block chloride conductance. In the absence of Zn2+, the GABA signalling response initially follows the canonical route until it reaches the pore. In contrast to synaptic GABAA receptors, expansion of the midway pore activation gate is limited and it remains closed, reflecting the intrinsic low efficacy that characterizes the extrasynaptic receptor. Overall, this study explains distinct traits adopted by αβ receptors that adapt them to a role in tonic signalling.
© 2022. The Author(s).

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35140402      PMCID: PMC8850191          DOI: 10.1038/s41586-022-04402-z

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  60 in total

1.  Zinc-mediated inhibition of GABA(A) receptors: discrete binding sites underlie subtype specificity.

Authors:  Alastair M Hosie; Emma L Dunne; Robert J Harvey; Trevor G Smart
Journal:  Nat Neurosci       Date:  2003-04       Impact factor: 24.884

2.  Single channel properties of recombinant GABAA receptors containing gamma 2 or delta subtypes expressed with alpha 1 and beta 3 subtypes in mouse L929 cells.

Authors:  J L Fisher; R L Macdonald
Journal:  J Physiol       Date:  1997-12-01       Impact factor: 5.182

3.  Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials.

Authors:  Samantha Meltzer-Brody; Helen Colquhoun; Robert Riesenberg; C Neill Epperson; Kristina M Deligiannidis; David R Rubinow; Haihong Li; Abdul J Sankoh; Christine Clemson; Amy Schacterle; Jeffrey Jonas; Stephen Kanes
Journal:  Lancet       Date:  2018-08-31       Impact factor: 79.321

4.  Delta subunit susceptibility variants E177A and R220H associated with complex epilepsy alter channel gating and surface expression of alpha4beta2delta GABAA receptors.

Authors:  Hua-Jun Feng; Jing-Qiong Kang; Luyan Song; Leanne Dibbens; John Mulley; Robert L Macdonald
Journal:  J Neurosci       Date:  2006-02-01       Impact factor: 6.167

5.  Functional characterization of the new human GABA(A) receptor mutation beta3(R192H).

Authors:  Andreas Buhr; Matt T Bianchi; Roland Baur; Philippe Courtet; Virginie Pignay; Jean P Boulenger; Sabina Gallati; David J Hinkle; Robert L Macdonald; Erwin Sigel
Journal:  Hum Genet       Date:  2002-07-16       Impact factor: 4.132

Review 6.  The Benzodiazepine Binding Sites of GABAA Receptors.

Authors:  Erwin Sigel; Margot Ernst
Journal:  Trends Pharmacol Sci       Date:  2018-04-30       Impact factor: 14.819

Review 7.  Extrasynaptic GABAA receptors: form, pharmacology, and function.

Authors:  Delia Belelli; Neil L Harrison; Jamie Maguire; Robert L Macdonald; Matthew C Walker; David W Cope
Journal:  J Neurosci       Date:  2009-10-14       Impact factor: 6.167

8.  Extrasynaptic alphabeta subunit GABAA receptors on rat hippocampal pyramidal neurons.

Authors:  Martin Mortensen; Trevor G Smart
Journal:  J Physiol       Date:  2006-10-05       Impact factor: 5.182

9.  Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease.

Authors:  Stephen G Brickley; Istvan Mody
Journal:  Neuron       Date:  2012-01-12       Impact factor: 17.173

Review 10.  The impact of tonic GABAA receptor-mediated inhibition on neuronal excitability varies across brain region and cell type.

Authors:  Vallent Lee; Jamie Maguire
Journal:  Front Neural Circuits       Date:  2014-02-03       Impact factor: 3.492

View more
  2 in total

Review 1.  Recent Insight into Lipid Binding and Lipid Modulation of Pentameric Ligand-Gated Ion Channels.

Authors:  Anna Ananchenko; Toka O K Hussein; Deepansh Mody; Mackenzie J Thompson; John E Baenziger
Journal:  Biomolecules       Date:  2022-06-10

2.  Molecular Mingling: Multimodal Predictions of Ligand Promiscuity in Pentameric Ligand-Gated Ion Channels.

Authors:  Filip Koniuszewski; Florian D Vogel; Konstantina Bampali; Jure Fabjan; Thomas Seidel; Petra Scholze; Philip B Schmiedhofer; Thierry Langer; Margot Ernst
Journal:  Front Mol Biosci       Date:  2022-05-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.